128 related articles for article (PubMed ID: 37902585)
21. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.
Arabanian LS; Johansson P; Staffas A; Nilsson T; Rouhi A; Fogelstrand L; Palmqvist L
Leuk Res; 2018 Dec; 75():61-68. PubMed ID: 30384975
[TBL] [Abstract][Full Text] [Related]
22. Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation.
Morgado E; Albouhair S; Lavau C
Blood; 2007 May; 109(9):4020-2. PubMed ID: 17202314
[TBL] [Abstract][Full Text] [Related]
23. A role for GPx3 in activity of normal and leukemia stem cells.
Herault O; Hope KJ; Deneault E; Mayotte N; Chagraoui J; Wilhelm BT; Cellot S; Sauvageau M; Andrade-Navarro MA; Hébert J; Sauvageau G
J Exp Med; 2012 May; 209(5):895-901. PubMed ID: 22508837
[TBL] [Abstract][Full Text] [Related]
24. Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines.
Wermuth PJ; Buchberg AM
Blood; 2005 Feb; 105(3):1222-30. PubMed ID: 15479723
[TBL] [Abstract][Full Text] [Related]
25.
Wang W; Li H; Huang M; Wang X; Li W; Qian X; Jing L
Open Biol; 2022 Oct; 12(10):220172. PubMed ID: 36285442
[No Abstract] [Full Text] [Related]
26. Dangerous liaisons: cooperation between Pbx3, Meis1 and Hoxa9 in leukemia.
Thorne RM; Milne TA
Haematologica; 2015 Jul; 100(7):850-3. PubMed ID: 26130510
[No Abstract] [Full Text] [Related]
27. Acceleration of chronic myeloproliferation by enforced expression of Meis1 or Meis3 in Icsbp-deficient bone marrow cells.
Hara T; Schwieger M; Kazama R; Okamoto S; Minehata K; Ziegler M; Löhler J; Stocking C
Oncogene; 2008 Jun; 27(27):3865-9. PubMed ID: 18223676
[TBL] [Abstract][Full Text] [Related]
28. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.
de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM
Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595
[TBL] [Abstract][Full Text] [Related]
29. C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis.
Collins C; Wang J; Miao H; Bronstein J; Nawer H; Xu T; Figueroa M; Muntean AG; Hess JL
Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9899-904. PubMed ID: 24958854
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
[TBL] [Abstract][Full Text] [Related]
31. Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice.
Moskow JJ; Bullrich F; Huebner K; Daar IO; Buchberg AM
Mol Cell Biol; 1995 Oct; 15(10):5434-43. PubMed ID: 7565694
[TBL] [Abstract][Full Text] [Related]
32. Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.
Argiropoulos B; Yung E; Xiang P; Lo CY; Kuchenbauer F; Palmqvist L; Reindl C; Heuser M; Sekulovic S; Rosten P; Muranyi A; Goh SL; Featherstone M; Humphries RK
Blood; 2010 May; 115(20):4071-82. PubMed ID: 20237320
[TBL] [Abstract][Full Text] [Related]
33. Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia.
Schneider E; Staffas A; Röhner L; Malmberg ED; Ashouri A; Krowiorz K; Pochert N; Miller C; Wei SY; Arabanian L; Buske C; Döhner H; Bullinger L; Fogelstrand L; Heuser M; Döhner K; Xiang P; Ruschmann J; Petriv OI; Heravi-Moussavi A; Hansen CL; Hirst M; Humphries RK; Rouhi A; Palmqvist L; Kuchenbauer F
Haematologica; 2018 Feb; 103(2):246-255. PubMed ID: 29217774
[TBL] [Abstract][Full Text] [Related]
34. Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation.
Mamo A; Krosl J; Kroon E; Bijl J; Thompson A; Mayotte N; Girard S; Bisaillon R; Beslu N; Featherstone M; Sauvageau G
Blood; 2006 Jul; 108(2):622-9. PubMed ID: 16469876
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality.
Rozovskaia T; Feinstein E; Mor O; Foa R; Blechman J; Nakamura T; Croce CM; Cimino G; Canaani E
Oncogene; 2001 Feb; 20(7):874-8. PubMed ID: 11314021
[TBL] [Abstract][Full Text] [Related]
36. The deficiency of tumor suppressor prep1 accelerates the onset of meis1- hoxa9 leukemogenesis.
Dardaei L; Modica L; Iotti G; Blasi F
PLoS One; 2014; 9(5):e96711. PubMed ID: 24809472
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16.
Ueda K; Yoshimi A; Kagoya Y; Nishikawa S; Marquez VE; Nakagawa M; Kurokawa M
Cancer Sci; 2014 May; 105(5):512-9. PubMed ID: 24612037
[TBL] [Abstract][Full Text] [Related]
38. Conditionally immortalised leukaemia initiating cells co-expressing Hoxa9/Meis1 demonstrate microenvironmental adaptation properties ex vivo while maintaining myelomonocytic memory.
Stahlhut M; Ha TC; Takmakova E; Morgan MA; Schwarzer A; Schaudien D; Eder M; Schambach A; Kustikova OS
Sci Rep; 2021 Mar; 11(1):5294. PubMed ID: 33674652
[TBL] [Abstract][Full Text] [Related]
39. Meis1 is critical to the maintenance of human acute myeloid leukemia cells independent of MLL rearrangements.
Liu J; Qin YZ; Yang S; Wang Y; Chang YJ; Zhao T; Jiang Q; Huang XJ
Ann Hematol; 2017 Apr; 96(4):567-574. PubMed ID: 28054140
[TBL] [Abstract][Full Text] [Related]
40. HOXA9 modulates its oncogenic partner Meis1 to influence normal hematopoiesis.
Hu YL; Fong S; Ferrell C; Largman C; Shen WF
Mol Cell Biol; 2009 Sep; 29(18):5181-92. PubMed ID: 19620287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]